Unaudited Financial Results For The Quarter Ended June 30, 2026.
Filed with BSE · · 11 pages · English
Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30, 2026.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 01 2026
- Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30, 2026.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 29 2026
- Announcement under Regulation 30 (LODR)-Allotment
Later from Venmax Drugs & Pharmaceuticals
- Statement Of Deviation & Variation
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 07 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 08 2026
- Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals